European Archives - Page 806 of 1272 - European Medical Journal

Editor’s Pick: Methotrexate and The Lung in Rheumatoid Arthritis

Methotrexate (MTX) is the most commonly used medication to treat RA. MTX pneumonitis (MTX-pneu) is a rare disease entity reported in MTX users.

Using Educational Applications to Facilitate Understanding of the Anatomy and Function of the Brain and Explore the Effects of Clinical Fatigue as from the Patient Perspective

When discussing the impact of rheumatic disease states with patients living with these conditions, fatigue is often at the forefront of that discussion…

Bone Health in Rheumatoid Arthritis: What Can Studies of Bone Microarchitecture Tell Us?

Rheumatoid arthritis (RA) is associated with changes in skeletal health, including increased risk of fracture.

Systemic Sclerosis

The purpose of this review is to provide a clinically focussed description of the relevant aetiopathogenesis, clinical expression of disease, approach to the assessment and treatment of Systemic Sclerosis, and highlight the recent advances and future challenges associated with this complex disease.

Using Audiometry to Track Atherosclerosis: Measuring a Beneficial Effect of Methotrexate in Rheumatoid Arthritis

To correlate audiometry with atherosclerosis. Presbycusis is associated with age and atherosclerosis; a strong correlation might present opportunities to…

The Role of Vitamin D in Disease Activity in Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory disease which predominantly involves the axial skeleton and sacroiliac joints.

Type 5 Collagen Regulates Scar Tissue Following Heart Attack

TYPE 5 collagen plays a crucial role in regulating scar tissue size in the heart and may explain why certain individuals experience…

Does COVID-19 Increase Mortality in Stroke?

GLOBAL COVID-19 Stroke Registry data show that acute ischaemic strokes (AIS) that occur in conjunction with COVID-19 are more severe…

Talking to Mircea Cubillos

Mircea Cubillos, Vice President Hematology EMEA, Commercial Strategy Lead, Janssen, discusses his lengthy career at Janssen, progression in oncology during COVID-19, and cultivating healthy habits during lockdown.

Stool Microbiome of Patients Indicate Cirrhosis Risk

MICROBIOTA from stool samples of patients with nonalcoholic fatty liver disease (NAFLD) may be used to predict which individuals are at greatest risk…